Lakefront Biotherapeutics Insider Trading
LKFT.XAMS
Lakefront Biotherapeutics's insiders don't report trades to the SEC
Insider trades on this page come from SEC Form 4 filings. LKFT.XAMS is a company from outside the US, so its directors report their trades to the market regulator in its home country instead, and there are no Form 4 filings to show. This is the case for most companies listed outside the US, and for foreign companies with US-listed shares.
See what insiders are buying in US companies
Open-market buys by executives and directors, from today's SEC filings.
Peers
Biotechnology · Pick stocks to compare with LKFT.XAMS
Held by ETFs
LKFT.XAMS is in 10 US ETFs. The largest of them, with LKFT.XAMS's weight in each:
Vanguard FTSE Europe ETFVGK0.01%of the fund
Vanguard FTSE All-World ex-US Small-Cap Index FundVSS0.04%of the fund
iShares Core MSCI Europe ETFIEUR0.01%of the fund
Schwab International Small-Cap Equity ETFSCHC0.06%of the fund
SPDR S&P International Small Cap ETFGWX0.08%of the fund
State Street SPDR Portfolio Europe ETFSPEU0.01%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing LKFT.XAMS
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.